MaxCyte, Inc. (MXCT): Capital Expenditures
$1.77M
Year ended 2025-12-31
$665.0K
Trailing 12 months to 2026-06-30
-54.3%
3-year compound annual growth
-3.1%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.77M | +7.1% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $1.65M | -55.4% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $3.70M | -80.0% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $18.48M | +381.9% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $3.83M | +85.0% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $2.07M | +63.0% | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | $1.27M | n/a | 2022-03-22, From 2019-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $1.77M | +7.1% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $565.0K | -69.9% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $62.0K | n/a |
| NRC Health (NRC) | 2025-12-31 | $10.71M | -30.7% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $60.6K | -23.4% |
| Absci Corp (ABSI) | 2025-12-31 | $1.11M | +174.0% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $454 | -98.6% |
| OneMedNet Corp (ONMD) | 2025-12-31 | $13.0K | -74.5% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $31.36M | -14.2% |
Compare MXCT, OABI, FOXO, NRC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗